Representative Dan Newhouse (R-Washington) recently bought shares of Synopsys, Inc. (NASDAQ:SNPS). In a filing disclosed on January 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in Synopsys stock on December 31st. The trade occurred in the Representative’s “EDWARD JONES IRA” account.
Representative Dan Newhouse also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Royal Caribbean Cruises (NYSE:RCL) on 12/31/2025.
- Purchased $1,001 – $15,000 in shares of Broadridge Financial Solutions (NYSE:BR) on 12/31/2025.
- Purchased $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 12/11/2025.
- Sold $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 12/11/2025.
- Purchased $1,001 – $15,000 in shares of T-Mobile US (NASDAQ:TMUS) on 12/11/2025.
- Purchased $1,001 – $15,000 in shares of Blackstone (NYSE:BX) on 12/11/2025.
- Purchased $1,001 – $15,000 in shares of Textron (NYSE:TXT) on 12/11/2025.
- Sold $1,001 – $15,000 in shares of Magna International (NYSE:MGA) on 12/11/2025.
- Sold $1,001 – $15,000 in shares of Truist Financial (NYSE:TFC) on 12/11/2025.
- Sold $1,001 – $15,000 in shares of Starbucks (NASDAQ:SBUX) on 12/11/2025.
Synopsys Stock Performance
NASDAQ:SNPS opened at $516.31 on Friday. The firm has a 50-day moving average of $455.35 and a two-hundred day moving average of $504.95. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The stock has a market cap of $98.78 billion, a P/E ratio of 64.62, a PEG ratio of 4.30 and a beta of 1.12. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73.
Hedge Funds Weigh In On Synopsys
Institutional investors have recently made changes to their positions in the stock. Stanley Laman Group Ltd. raised its stake in shares of Synopsys by 542.9% during the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after purchasing an additional 10,874 shares in the last quarter. Symphony Financial Ltd. Co. raised its position in Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Synopsys by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after acquiring an additional 4,815 shares during the last quarter. Westbourne Investments Inc. bought a new stake in Synopsys in the second quarter worth approximately $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in Synopsys by 1.7% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock worth $91,660,000 after acquiring an additional 2,991 shares in the last quarter. 85.47% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.62% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Citigroup began coverage on shares of Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Finally, Morgan Stanley lifted their price target on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Synopsys has a consensus rating of “Hold” and a consensus target price of $553.57.
Check Out Our Latest Research Report on Synopsys
About Representative Newhouse
Dan Newhouse (Republican Party) is a member of the U.S. House, representing Washington’s 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Newhouse (Republican Party) ran for re-election to the U.S. House to represent Washington’s 4th Congressional District. He won in the general election on November 5, 2024.
Click here to see Newhouse’s key votes in Congress.
Newhouse served as a member of the Washington House of Representatives representing District 15-Position 2 from 2003 through 2009 and as Washington Director of Agriculture from 2009 to 2013.
Newhouse was first elected to the state House in 2002 and served until he was named state Director of Agriculture in 2009. He was first appointed by Governor Christine Gregoire on February 18, 2009.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street Alert: Buy AES
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
